Healthcare Roundup – Gilead Sciences Q1 2020 Earnings Preview, FDA OKs expanded use of Glaxo’s Zejula April 30, 2020 Life Science
Healthcare Roundup – Roche’s entrectinib OK’d in Canada, Sarepta up 5% premarket on COVID-19 plan April 28, 2020 Life Science
Healthcare Roundup —— Sorrento Therapeutics in deal for up to $250M, Moderna submits IND application for Phase 2 COVID-19 study April 27, 2020 Life Science
Green Valley Obtains IND Approval from U.S. FDA for Sodium Oligomannate’s International, Phase III Clinical Study April 27, 2020 Life Science
Hua Medicine Announces Positive Results of the Combination Study of Dorzagliatin with Empagliflozin (a SGLT-2 inhibitor) April 27, 2020 Life Science
Healthcare Roundup – Translate Bio jumps 21% on bullish comments from vaccine partner Sanofi, Gilead’s remdesivir trial ahead of schedule April 24, 2020 Life Science
AkesoBio Completes $335 Million Hong Kong IPO; Climbs 50% on First Trading Day April 24, 2020 Life Science
Hansoh Pharma and NiKang Therapeutics Enter into a Development and Commercialization Partnership for a Novel Treatment for Anti-Viral Diseases in China April 24, 2020 Life Science
Healthcare Roundup – European regulators on board with Mylan/Upjohn tie-up, BioCryst feels Gilead’s remdesivir pain April 23, 2020 Life Science
Healthcare Roundup – Liberty Health Sciences updates business amid COVID-19, Atyr Pharma on go with study of lead drug in COVID-19 April 22, 2020 Life Science
Healthcare Roundup – Another U.S. study points to far higher rate of COVID infection, Money flow spikes in COVID-19 vaccine players amid rush for early data April 21, 2020 Life Science
Transcenta Received IND Clearance from FDA for Initiating Clinical Trials for its Novel Humanized Claudin 18.2 Monoclonal Antibody TST001 April 20, 2020 Life Science
Fosun Pharma Receives FDA Emergency Use Authorization (EUA) For Its COVID-19 RT-PCR Detection Kit April 20, 2020 Life Science
Healthcare Roundup – U.S. COVID-19 testing capacity still constrained, Sanofi can produce up to 600M doses of COVID-19 vaccine April 17, 2020 Life Science
Healthcare Roundup – Gilead up 6% after hours on remdesivir buzz in COVID-19, New York, East Coast states extend lockdown to May 15 April 16, 2020 Life Science